Cancer immunotherapy: yesterday and tomorrow.
A great deal has been said and written about the development of our capacity to treat cancer by immunization or to immunize against cancer. But this is far from being available in the immediate future. This is why we believe it is important to place immunotherapy in its historical context, to understand its specific role and to state clearly what may be expected from it. Surgery is, whenever possible, the primary method of treating a patient with a surgically accessible tumor. Surgical removal should be as extended and careful as possible. Sometimes the mass of the tumor is such that it is necessary to reduce it by radiotherapy or chemotherapy prior to surgery.
Orbach-Arbouys
S
S
Institut du Cancer et d'Immunogénétique, Hôpital Paul-Brousse, Villejuif, France.
Hillova
J
J
D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D009369:Neoplasms / Q000628:therapy*